SHILPA MEDICARE share price has zoomed 7% and is presently trading at Rs 780.0.
Meanwhile, the BSE HEALTHCARE index is at 42,404.8 (up 0.6%).
Among the top gainers in the BSE HEALTHCARE index today are Jubilant Pharmova (up 3.1%) and Pfizer (up 2.5%).
ASTER DM HEALTHCARE (down 0.8%) and POLY MEDICURE (down 0.6%) are among the top losers today.
Over the last one year, SHILPA MEDICARE has moved up from Rs 365.7 to Rs 780.0, registering a gain of Rs 414.4 (up 113.3%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,099.5 to 42,404.8, registering a gain of 50.9% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 130.8%), Glenmark Pharma (up 125.5%) and SUVEN PHARMACEUTICALS (up 110.2%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 81,655.3 (down 0.1%).
The top losers among the BSE Sensex today are JSW Steel (down 1.2%) and Kotak Bank (down 0.8%). The most traded stocks in the BSE Sensex are Tata Steel and HCl Tech..
In the meantime, NSE Nifty is at 24,995.9 (down 0.1%). BPCL and Shriram Transport are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,433.3 to 81,655.3, registering a gain of 16,222.0 points (up 24.8%).
SHILPA MEDICARE net profit grew 519.2% YoY to Rs 176 million for the quarter ended June 2024, compared to a profit of Rs 28 million a year ago. Net sales rose 12.4% to Rs 2,925 million during the period as against Rs 2,602 million in April-June 2023.
For the year ended March 2023, SHILPA MEDICARE reported 151.0% decrease in net profit to Rs -309 million compared to net profit of Rs 606 million during FY22. Revenue of the company fell 8.3% to Rs 10,501 million during FY23.
The current Price to earnings ratio of SHILPA MEDICARE, based on rolling 12 month earnings, stands at 148.2.
Equitymaster requests your view! Post a comment on "SHILPA MEDICARE Gains 7%; BSE HEALTHCARE Index Up 0.6%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!